Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of rotavirus strains and severity of gastroenteritis in Indian children.
Saluja T, Dhingra MS, Sharma SD, Gupta M, Kundu R, Kar S, Dutta AK, Silveira MD, Singh JV, Kamath VG, Chaudhary A, Rao V, Ravi MD, Murthy K, Arumugam R, Moureau A, Prasad R, Patnaik BN. Saluja T, et al. Among authors: gupta m. Hum Vaccin Immunother. 2017 Mar 4;13(3):711-716. doi: 10.1080/21645515.2016.1238994. Epub 2016 Sep 29. Hum Vaccin Immunother. 2017. PMID: 27686522 Free PMC article.
Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.
Gandhi DJ, Dhaded SM, Ravi MD, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Jayanth MV, Ravinuthala S, Sil A, Dhingra MS. Gandhi DJ, et al. Among authors: gupta m. Hum Vaccin Immunother. 2016 Apr 2;12(4):946-54. doi: 10.1080/21645515.2015.1100779. Epub 2015 Nov 18. Hum Vaccin Immunother. 2016. PMID: 26580093 Free PMC article. Clinical Trial.
Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
Sil A, Ravi MD, Patnaik BN, Dhingra MS, Dupuy M, Gandhi DJ, Dhaded SM, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Rout SP, Jayanth MV, D'Cor NA, Mangarule SA, Ravinuthala S, Reddy E J. Sil A, et al. Among authors: gupta m. Vaccine. 2017 May 19;35(22):2999-3006. doi: 10.1016/j.vaccine.2017.03.009. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449972 Free article. Clinical Trial.
Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja T, Palkar S, Misra P, Gupta M, Venugopal P, Sood AK, Dhati RM, Shetty A, Dhaded SM, Agarkhedkar S, Choudhury A, Kumar R, Balasubramanian S, Babji S, Adhikary L, Dupuy M, Chadha SM, Desai F, Kukian D, Patnaik BN, Dhingra MS. Saluja T, et al. Among authors: gupta m. Vaccine. 2017 Jun 16;35(28):3575-3581. doi: 10.1016/j.vaccine.2017.05.019. Epub 2017 May 20. Vaccine. 2017. PMID: 28536027 Clinical Trial.
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study.
Susarla SK, Gupta M, Mantan M, Dhongade R, Bhave S, Das RK, Ray RK, Ramesh Babu T, Ravi MD, Krishnamurthy B, James S, Sandhya G, Satish M, Sahoo DP. Susarla SK, et al. Among authors: gupta m. Vaccine. 2019 Aug 23;37(36):5452-5459. doi: 10.1016/j.vaccine.2019.06.067. Epub 2019 Jul 19. Vaccine. 2019. PMID: 31331773 Clinical Trial.
Research priorities in Maternal, Newborn, & Child Health & Nutrition for India: An Indian Council of Medical Research-INCLEN Initiative.
Arora NK, Swaminathan S, Mohapatra A, Gopalan HS, Katoch VM, Bhan MK, Rasaily R, Shekhar C, Thavaraj V, Roy M, Das MK, Wazny K, Kumar R, Khera A, Bhatla N, Jain V, Laxmaiah A, Nair MKC, Paul VK, Ramachandran P, Ramji S, Vaidya U, Verma IC, Shah D, Bahl R, Qazi S, Rudan I, Black RE; ICMR INCLEN Research Priority Setting Network; National Steering Group; Research Sub-Committee; Nation-wide Network. Arora NK, et al. Indian J Med Res. 2017 May;145(5):611-622. doi: 10.4103/ijmr.IJMR_139_17. Indian J Med Res. 2017. PMID: 28948951 Free PMC article.
Rotavirus vaccine impact assessment surveillance in India: protocol and methods.
Nair NP, Reddy N S, Giri S, Mohan VR, Parashar U, Tate J, Shah MP, Arora R, Gupte M, Mehendale SM; Investigators of the Rotavirus vaccine Impact Surveillance Network; Kang G. Nair NP, et al. BMJ Open. 2019 Apr 25;9(4):e024840. doi: 10.1136/bmjopen-2018-024840. BMJ Open. 2019. PMID: 31028037 Free PMC article.
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.
Susarla SK, Gupta M, Uttam KG, Palkar S, Dhongade AR, Siva Ram Prasad K, Rajapantula V, Ravi MD, Pradeep N, Satish M, Rajashakar BC, Sandhya G, Rajendra L, Sahoo DP, Kanakasapapathy AK. Susarla SK, et al. Among authors: gupta m. Vaccine. 2023 Oct 6;41(42):6215-6220. doi: 10.1016/j.vaccine.2023.08.084. Epub 2023 Sep 1. Vaccine. 2023. PMID: 37661535 Clinical Trial.
8,278 results